
LSDI
Healthcare · Drug Manufacturers - Specialty & Generic · $906,910 market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Mar 31, 2024
EPS trend, 90 days to now · +100.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Feb 13, 2024 | After the close | -0.03 | -0.14 | -366.7% |
| Oct 13, 2023 | After the close | -0.16 | -0.20 | -25.0% |
| Aug 30, 2023 | Time not confirmed | -0.19 | -0.19 | 0.0% |
| May 10, 2023 | After the close | — | -0.30 | — |
| Feb 6, 2023 | Time not confirmed | — | -0.08 | — |
| Mar 4, 2022 | Time not confirmed | — | -0.09 | — |
Lucy Scientific Discovery Inc., an early stage psychotropics contract manufacturing company, engaged in the research, manufacturing, and commercialization of psychedelic products. The company offers biological raw materials, active pharmaceutical ingredients (APIs), and finished biopharmaceutical products. It also develops and produces highly controlled agricultural grow environments for plant manufacturing and…